Niagen Bioscience (NAGE) Insider Shahbazi Buys 31,746 Shares

Insider Buying and Selling at Niagen Bioscience, Inc.

Hamed Shahbazi purchased 31,746 shares of Niagen Bioscience, Inc. (NAGE) on June 24, 2026, at a price of $3.42 each. This transaction adds to a series of insider buys that day, where several executives increased their holdings in the company.

Collective Insider Moves

In total, multiple insiders bought 31,746 shares each on the same day. This includes Yu Wing Tak Wendy, Steven Rubin, Kristin Patrick, Ann Cohen, Ng Wang Yu Gary, and Jaksch Frank Jr. All these purchases reflect a concerted effort by the management team to show confidence in Niagen's future.

How Niagen Bioscience, Inc. Stock Has Traded

Niagen Bioscience's stock closed at $3.42 on the day of the transaction. It has traded between a 52-week low of $2.87 and a high of $10.52. The stock's current position suggests that it remains below its historical highs, which could be a point of interest for investors.

What Niagen Bioscience, Inc. Does

Niagen Bioscience, Inc. focuses on developing products that promote healthy aging. The company offers dietary supplements that contain its proprietary ingredients, including nicotinamide adenine dinucleotide (NAD+), which is important for cellular metabolism. With a market cap of approximately $240.5 million, its performance in the consumer defensive sector is under close observation.

What's Next for Niagen Bioscience, Inc.

The next earnings report for Niagen Bioscience is scheduled for November 3, 2026. As the company prepares for this announcement, these insider purchases may be viewed as a positive sign by the market. It's important to note that these transactions reflect past actions and may not represent the current positions of the insiders.